Authors:
BONI JP
DECLEENE SA
CEVALLOS WH
HICKS DR
KORTHBRADLEY JM
Citation: Jp. Boni et al., EFFECTS OF AGE AND GENDER ON THE PHARMACOKINETICS OF BROMFENAC IN HEALTHY-VOLUNTEERS, The Annals of pharmacotherapy, 31(4), 1997, pp. 400-405
Authors:
BONI JP
CEVALLOS WH
DECLEENE S
KORTHBRADLEY JM
Citation: Jp. Boni et al., THE INFLUENCE OF BROMFENAC ON THE PHARMACOKINETICS AND PHARMACODYNAMIC RESPONSES TO GLYBURIDE IN DIABETIC SUBJECTS, Pharmacotherapy, 17(4), 1997, pp. 783-790
Authors:
ERMER JC
BONI JP
CEVALLOS WH
DECLEENE S
BURGHART P
RUDNICK MR
FRUNCILLO RJ
BERNS JS
COHEN RM
Citation: Jc. Ermer et al., BROMFENAC DISPOSITION IN PATIENTS WITH IMPAIRED KIDNEY-FUNCTION, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 312-318
Authors:
GREENBERGER LM
COLLINS KI
ANNABLE T
BONI JP
MAY MK
LAI FM
KRAMER R
CITERALLA RV
HALLETT WA
POWELL D
Citation: Lm. Greenberger et al., ETHYLPHENYL)THIO]-2(1H)-ISOQUINOLINEHEPTANENITRILE (CL-329,753) - A NOVEL CHEMOSENSITIZING AGENT FOR P-GLYCOPROTEIN-MEDIATED RESISTANCE WITH IMPROVED BIOLOGICAL PROPERTIES COMPARED WITH VERAPAMIL AND CYCLOSPORINE-A, Oncology research, 8(5), 1996, pp. 207-218